Leif Niclas Fredrik Löwgren
Director/Board Member at Omnivation AB
Profile
Leif Niclas Fredrik Löwgren is currently a Director at Omnivation AB.
He was previously a Director at Copperstone Resources AB, QuiaPEG Pharmaceuticals AB, NextCell Pharma AB, and Quiapeg Pharmaceuticals Holding AB.
Mr. Löwgren holds an MBA from the University of Stockholm.
Leif Niclas Fredrik Löwgren active positions
Companies | Position | Start |
---|---|---|
Omnivation AB | Director/Board Member | - |
Former positions of Leif Niclas Fredrik Löwgren
Companies | Position | End |
---|---|---|
COPPERSTONE RESOURCES AB | Director/Board Member | 2019-05-13 |
NEXTCELL PHARMA AB | Director/Board Member | - |
QUIAPEG PHARMACEUTICALS HOLDING AB | Director/Board Member | - |
QuiaPEG Pharmaceuticals AB
QuiaPEG Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology QuiaPEG Pharmaceuticals AB operates as biotech company developing biopharmaceuticals based on a proprietary PEGylation technology platform. The firm’s technology is applicable on proteins, peptides, and small molecules. It develops novel long-acting biopharmaceuticals for the treatment of metabolic disorders. The company was founded by Hans Marcus Bosson in 2012 and is headquartered in Solna, Sweden. | Director/Board Member | - |
Training of Leif Niclas Fredrik Löwgren
University of Stockholm | Masters Business Admin |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 3 |
---|---|
COPPERSTONE RESOURCES AB | Non-Energy Minerals |
NEXTCELL PHARMA AB | Health Technology |
QUIAPEG PHARMACEUTICALS HOLDING AB | Health Technology |
Private companies | 2 |
---|---|
QuiaPEG Pharmaceuticals AB
QuiaPEG Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology QuiaPEG Pharmaceuticals AB operates as biotech company developing biopharmaceuticals based on a proprietary PEGylation technology platform. The firm’s technology is applicable on proteins, peptides, and small molecules. It develops novel long-acting biopharmaceuticals for the treatment of metabolic disorders. The company was founded by Hans Marcus Bosson in 2012 and is headquartered in Solna, Sweden. | Health Technology |
Omnivation AB |
- Stock Market
- Insiders
- Leif Niclas Fredrik Löwgren